Gonorrhoea vaccine - AdaptVac/Oregon State University
Latest Information Update: 28 Feb 2023
At a glance
- Originator AdaptVac; Oregon State University
- Class Bacterial vaccines; Subunit vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Gonorrhoea
Most Recent Events
- 30 Jan 2023 Preclinical trials in Gonorrhoea (Prevention) in Denmark (Parenteral) (AdaptVac pipeline; January 2023)